SEP 28, 2026 · JOURNAL ARTICLE
Delayed and multisystem immune-related adverse events in MSI-high colon cancer treated with nivolumab plus ipilimumab
Clinical Journal of Gastroenterology
Abstract Immune checkpoint inhibitors (ICIs) can cause immune-related adverse events (irAEs) involving multiple organs. However, delayed-onset, multisystem irAEs after treatment di